Diabetes
55:1205-1213,
2006
DOI: 10.2337/db05-1304
© 2006 by the American Diabetes Association
Mature-Onset Obesity in Interleukin-1 Receptor I Knockout Mice
Maria C. García1,
Ingrid Wernstedt1,
Anna Berndtsson1,
Maria Enge1,
Michal Bell2,
Olof Hultgren3,
Michael Horn4,
Bo Ahrén5,
Sven Enerback2,
Claes Ohlsson6,
Ville Wallenius1, and
John-Olov Jansson1
1 Department of Physiology and Wallenberg Laboratory, Göteborg University, Göteborg, Sweden
2 Medical Genetics Department of Medical Biochemistry, Göteborg University, Göteborg, Sweden
3 Department of Clinical Immunology, Göteborg University, Göteborg, Sweden
4 Department of Radiation Physics, Institute of Selected Sciences, Sahlgrenska Academy, Göteborg University, Göteborg, Sweden
5 Department of Medicine, Lund University, Malmö, Sweden
6 Research Centre for Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden
Address correspondence and reprint requests to John-Olov Jansson, Department of Physiology, Medicinargatan 9A, SE-405 30 Gothenburg, Sweden. E-mail: john-olov.jansson{at}medic.gu.se
Abbreviations:
DEXA, dual-energy X-ray absorptiometry; IL-1, interleukin-1; IL-1Ra, IL-1 receptor antagonist; IL-1RI, IL-1 type I receptor; LBM, lean body mass; MC4-R, melanocortin-4 receptor; MRI, magnetic resonance imaging; RER, respiratory exchange ratio; WAT, white adipose tissue
Interleukin-1 (IL-1) is a major mediator of inflammation that exerts its biological activities through the IL-1 type I receptor (IL-1RI). The body weights of IL-1RI–/– mice of both sexes started to deviate from those of wild-type mice at 5–6 months of age and were 20% higher at 9 months of age. Visceral and subcutaneous fat mass, measured by dual-energy X-ray absorptiometry and magnetic resonance imaging, was markedly (1.5- to 2.5-fold) increased. Lean body mass and crown-rump length were also slightly (11 and 5%, respectively) increased, as was serum IGF-I. Obese IL-1RI–/– mice were insulin resistant, as evidenced by hyperinsulinemia, decreased glucose tolerance, and insulin sensitivity. To elucidate the mechanisms for the development of obesity, young preobese IL-1RI–/– mice were investigated. They showed decreased suppression of body weight and food intake in response to systemic leptin treatment. The decreased leptin responsiveness was even more pronounced in older obese animals. Moreover, spontaneous locomotor activity and fat utilization, as measured by respiratory quotient, were decreased in preobese IL-1RI–/– mice. In conclusion, lack of IL-1RI–mediated biological activity causes mature-onset obesity. This obese phenotype is preceded by decreased leptin sensitivity, fat utilization, and locomotor activity.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. J. Hausman, C. R. Barb, and R. G. Dean
Patterns of gene expression in pig adipose tissue: Transforming growth factors, interferons, interleukins, and apolipoproteins
J Anim Sci,
October 1, 2007;
85(10):
2445 - 2456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Scarlett, E. E. Jobst, P. J. Enriori, D. D. Bowe, A. K. Batra, W. F. Grant, M. A. Cowley, and D. L. Marks
Regulation of Central Melanocortin Signaling by Interleukin-1{beta}
Endocrinology,
September 1, 2007;
148(9):
4217 - 4225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Manneras, S. Cajander, A. Holmang, Z. Seleskovic, T. Lystig, M. Lonn, and E. Stener-Victorin
A New Rat Model Exhibiting Both Ovarian and Metabolic Characteristics of Polycystic Ovary Syndrome
Endocrinology,
August 1, 2007;
148(8):
3781 - 3791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Shen, D. K. Arnett, J. M. Peacock, L. D. Parnell, A. Kraja, J. E. Hixson, M. Y. Tsai, C.-Q. Lai, E. K. Kabagambe, R. J. Straka, et al.
Interleukin1{beta} Genetic Polymorphisms Interact with Polyunsaturated Fatty Acids to Modulate Risk of the Metabolic Syndrome
J. Nutr.,
August 1, 2007;
137(8):
1846 - 1851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. P. Zorrilla, M. Sanchez-Alavez, S. Sugama, M. Brennan, R. Fernandez, T. Bartfai, and B. Conti
Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency
PNAS,
June 26, 2007;
104(26):
11097 - 11102.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Larsen, M. Faulenbach, A. Vaag, A. Volund, J. A. Ehses, B. Seifert, T. Mandrup-Poulsen, and M. Y. Donath
Interleukin-1-Receptor Antagonist in Type 2 Diabetes Mellitus
N. Engl. J. Med.,
April 12, 2007;
356(15):
1517 - 1526.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sanchez-Alavez, I. Klein, S. E. Brownell, I. V. Tabarean, C. N. Davis, B. Conti, and T. Bartfai
Night eating and obesity in the EP3R-deficient mouse
PNAS,
February 20, 2007;
104(8):
3009 - 3014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Strandberg, M. Lorentzon, A. Hellqvist, S. Nilsson, V. Wallenius, C. Ohlsson, and J.-O. Jansson
Interleukin-1 System Gene Polymorphisms Are Associated with Fat Mass in Young Men
J. Clin. Endocrinol. Metab.,
July 1, 2006;
91(7):
2749 - 2754.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Diabetes Association.
|
|
| |
|